Breaking News Instant updates and real-time market news.

IEP

Icahn Enterprises

$36.06 /

-6.55 (-15.37%)

15:57
03/23/20
03/23
15:57
03/23/20
15:57

Icahn Enterprises confirms intent to maintain $2.00 per unit dividend

In response to investor inquiries and market speculation, Icahn Enterprises confirmed that it is the intention of the Board of Directors of the general partner of Icahn Enterprises to maintain the regular quarterly distribution, in the amount of $2.00 per depositary unit, for the foreseeable future. Depositary unitholders will continue to have the right to make an election each quarter to receive either cash or additional depositary units; if a unitholder does not make an election, it will automatically be deemed to have elected to receive the distribution in cash. "Icahn Enterprises and its subsidiaries maintain ample liquidity to take advantage of attractive opportunities for their respective businesses. Icahn Enterprises' liquid assets - comprised of cash and cash equivalents and investments in the investment funds comprising Icahn Enterprises' Investment segment - totaled over $6 billion as of March 20, 2020. This does not include the indicative net asset value of Icahn Enterprises' operating subsidiaries, which totaled approximately $5.5 billion as of December 31," the master limited partnership said.

TODAY'S FREE FLY STORIES

Hot Stocks
Ferroglobe announces 'unqualified' audit opinion including going concern » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
GSM

Ferroglobe

$0.71 /

-0.0441 (-5.84%)

Ferroglobe filed its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

09/16/19 Stifel
Ferroglobe downgraded to Hold from Buy at Stifel
GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

Hot Stocks
Xperi, TiVo announce completion of merger, TIVO no longer listed for trading » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
XPER

Xperi

$13.76 /

-0.36 (-2.55%)

, TIVO

TiVo

$6.21 /

-0.21 (-3.27%)

Xperi Holding announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

XPER Xperi
$13.76 /

-0.36 (-2.55%)

08:21 Today B. Riley FBR
Xperi price target raised to $35 from $31 at B. Riley FBR
05/07/20 Craig-Hallum
Xperi price target lowered to $20 from $25 at Craig-Hallum
02/24/20 B. Riley FBR
Xperi worth 55% more than Metis takeover proposal, says B. Riley FBR
02/19/20 B. Riley FBR
TiVo price target raised to $21 from $19 at B. Riley FBR
TIVO TiVo
$6.21 /

-0.21 (-3.27%)

08:21 Today B. Riley FBR
Xperi price target raised to $35 from $31 at B. Riley FBR
03/12/20 B. Riley FBR
TiVo attractive in uncertain COVID-19 environment, says B. Riley FBR
03/03/20 B. Riley FBR
InterDigital 2020 outlook not at risk from coronavirus, says B. Riley FBR
02/24/20 B. Riley FBR
Xperi worth 55% more than Metis takeover proposal, says B. Riley FBR
XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

Hot Stocks
Resideo names Phillip Theodore as Chief Transformation Officer » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
REZI

Resideo

$7.08 /

+0.52 (+7.93%)

Resideo Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$7.08 /

+0.52 (+7.93%)

REZI Resideo
$7.08 /

+0.52 (+7.93%)

04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
02/28/20 Imperial Capital
Resideo upgraded to Outperform from In-Line at Imperial Capital
REZI Resideo
$7.08 /

+0.52 (+7.93%)

Hot Stocks
Equity Residential provides quarter-to-date statistics for Q2 » 08:40
06/01/20
06/01
08:40
06/01/20
08:40
EQR

Equity Residential

$60.57 /

-0.3 (-0.49%)

Equity Residential…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

05/18/20 BofA
BofA upgrades Camden Property to Buy, cuts Equity Residential, Aimco
05/18/20 BofA
Equity Residential downgraded to Neutral from Buy at BofA
05/10/20 Evercore ISI
Equity Residential upgraded to In Line from Underperform at Evercore ISI
04/24/20 Piper Sandler
Equity Residential downgraded to Underweight from Neutral at Piper Sandler
EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

Recommendations
Surmodics price target raised to $76 from $50 at Lake Street » 08:40
06/01/20
06/01
08:40
06/01/20
08:40
SRDX

Surmodics

$37.01 /

-1.42 (-3.70%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRDX Surmodics
$37.01 /

-1.42 (-3.70%)

02/06/20 Barrington
Surmodics price target lowered to $56 from $62 at Barrington
02/06/20 Lake Street
Surmodics upgraded to Buy from Hold at Lake Street
12/11/19 Needham
Surmodics downgraded to Hold from Buy at Needham
11/01/19 Lake Street
Surmodics downgraded to Hold from Buy at Lake Street
SRDX Surmodics
$37.01 /

-1.42 (-3.70%)

Hot Stocks
Resverlogix plans COVID-19 trial program launch » 08:40
06/01/20
06/01
08:40
06/01/20
08:40

Resverlogix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
ANI Pharmaceuticals provides update regarding Cortrophin Gel sNDA filing » 08:39
06/01/20
06/01
08:39
06/01/20
08:39
ANIP

ANI Pharmaceuticals

$31.15 /

-0.71 (-2.23%)

ANI Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

05/08/20 Raymond James
ANI Pharmaceuticals price target lowered to $49 from $65 at Raymond James
05/07/20 Cantor Fitzgerald
Cantor downgrades ANI Pharmaceuticals to Neutral on near-term uncertainty
05/07/20 Cantor Fitzgerald
ANI Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
09/11/19 Guggenheim
ANI Pharmaceuticals initiated with a Buy at Guggenheim
ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

Hot Stocks
SurveyMonkey announces return to work offering for enterprise customers » 08:38
06/01/20
06/01
08:38
06/01/20
08:38
SVMK

SurveyMonkey

$20.15 /

+0.58 (+2.96%)

SurveyMonkey announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

05/18/20 Wells Fargo
Wells upgrades SurveyMonkey to Overweight on resilience, increasing relevance
05/18/20 Wells Fargo
SurveyMonkey upgraded to Overweight from Equal Weight at Wells Fargo
05/14/20 Needham
SurveyMonkey initiated with a Buy at Needham
01/17/20 Wells Fargo
SurveyMonkey price target raised to $21 from $18 at Wells Fargo
SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

Hot Stocks
Iterum Therapeutics evaluating corporate, strategic, financial alternatives » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ITRM

Iterum Therapeutics

$4.23 /

-0.14 (-3.20%)

Based on the trial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

Hot Stocks
Iterum says Phase 3 trial of sulopenem did not meet primary endpoint » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ITRM

Iterum Therapeutics

$4.23 /

-0.14 (-3.20%)

Iterum Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

Recommendations
Canopy Growth price target lowered to C$24 from C$30 at Alliance Global Partners » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
CGC

Canopy Growth

$17.36 /

-4.37 (-20.11%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

06:30 Today BMO Capital
Canopy Growth downgraded to Market Perform from Outperform at BMO Capital
06:26 Today CIBC
Canopy Growth downgraded to Neutral from Outperformer at CIBC
05:37 Today Stifel
Stifel double downgrades Canopy Growth to Sell on 'course correction'
05:30 Today CIBC
Canopy Growth downgraded to Neutral from Outperformer at CIBC
CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

Hot Stocks
Anixa Biosciences, OntoChem synthesize four potential COVID-19 compounds » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ANIX

Anixa Biosciences

$2.29 /

-0.005 (-0.22%)

Anixa Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANIX Anixa Biosciences
$2.29 /

-0.005 (-0.22%)

ANIX Anixa Biosciences
$2.29 /

-0.005 (-0.22%)

12/30/19 B. Riley FBR
Anixa Biosciences price target lowered to $8 from $11.25 at B. Riley FBR
Hot Stocks
Eldorado Resorts to open 3 Missouri casinos, 2 Iowa casinos » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
ERI

Eldorado Resorts

$35.52 /

+0.79 (+2.27%)

Eldorado Resorts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

05/12/20 Deutsche Bank
Eldorado Resorts price target lowered to $28 from $68 at Deutsche Bank
05/12/20 Jefferies
Eldorado Resorts price target raised to $38 from $29 at Jefferies
04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

Recommendations
Burlington Stores price target raised to $250 from $184 at RBC Capital » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
BURL

Burlington Stores

$209.70 /

-3.735 (-1.75%)

RBC Capital analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

05/29/20 DA Davidson
Burlington Stores price target raised to $250 from $215 at DA Davidson
05/29/20 Loop Capital
Burlington Stores price target lowered to $250 from $265 at Loop Capital
05/29/20 Citi
Burlington Stores price target raised to $250 from $205 at Citi
05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

Hot Stocks
EIB, Voxeljet expand partnership to bring 3D printing into series production » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
VJET

Voxeljet

$1.12 /

-0.02 (-1.75%)

Voxeljet announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VJET Voxeljet
$1.12 /

-0.02 (-1.75%)

VJET Voxeljet
$1.12 /

-0.02 (-1.75%)

10/29/19 Piper Jaffray
Piper 3D printing survey brings better feedback in Q3
08/18/19 Piper Jaffray
Voxeljet price target lowered to $3 from $4.75 at Piper Jaffray
Hot Stocks
Revance, Mylan to advance development program for Botox biosimilar » 08:35
06/01/20
06/01
08:35
06/01/20
08:35
RVNC

Revance

$20.88 /

-0.46 (-2.16%)

, MYL

Mylan

$17.10 /

-0.15 (-0.87%)

Revance Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVNC Revance
$20.88 /

-0.46 (-2.16%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

RVNC Revance
$20.88 /

-0.46 (-2.16%)

03/27/20 H.C. Wainwright
Revance price target lowered to $24 from $28 at H.C. Wainwright
03/23/20
Fly Intel: Top five analyst downgrades
03/22/20 Goldman Sachs
Revance downgraded to Neutral from Buy at Goldman Sachs
02/26/20 H.C. Wainwright
Revance price target raised to $28 from $23 at H.C. Wainwright
MYL Mylan
$17.10 /

-0.15 (-0.87%)

03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
02/05/20 Baird
Biogen price target raised to $290 from $250 at Baird
02/05/20 Mizuho
Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
RVNC Revance
$20.88 /

-0.46 (-2.16%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

Hot Stocks
Twin River Worldwide to open nearly entire portfolio of operating casinos » 08:35
06/01/20
06/01
08:35
06/01/20
08:35
TRWH

Twin River Worldwide

$20.95 /

+0.24 (+1.16%)

Twin River Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

05/29/20 SunTrust
Twin River Worldwide price target raised to $25 from $20 at SunTrust
04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/17/20 SunTrust
Twin River Worldwide upgraded to Buy from Hold at SunTrust
02/12/20 SunTrust
Twin River Worldwide price target raised to $31 from $26 at SunTrust
TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

General news
Oil Action: July WTI crude » 08:35
06/01/20
06/01
08:35
06/01/20
08:35

Oil Action: July WTI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
WNS Holdings elevated to Fresh Pick at Baird » 08:34
06/01/20
06/01
08:34
06/01/20
08:34
WNS

WNS Holdings

$48.37 /

+0.13 (+0.27%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

04/24/20 Deutsche Bank
WNS Holdings price target lowered to $56 from $81 at Deutsche Bank
04/23/20 Needham
WNS Holdings downgraded to Buy from Strong Buy at Needham
04/21/20 Cowen
WNS Holdings price target lowered to $57 from $77 at Cowen
04/17/20 Wells Fargo
WNS Holdings downgraded to Equal Weight from Overweight at Wells Fargo
WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

Hot Stocks
Cancer Genetics: 'Substantial doubts' about ability continue as going concern » 08:33
06/01/20
06/01
08:33
06/01/20
08:33
CGIX

Cancer Genetics

$3.10 /

+0.14 (+4.73%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGIX Cancer Genetics
$3.10 /

+0.14 (+4.73%)

CGIX Cancer Genetics
$3.10 /

+0.14 (+4.73%)

Hot Stocks
Equinix acquires 13 data centers across Canada from BCE for $750M in cash » 08:32
06/01/20
06/01
08:32
06/01/20
08:32
EQIX

Equinix

$698.03 /

+4.68 (+0.67%)

, BCE

BCE

$41.50 /

+0.125 (+0.30%)

Equinix (EQIX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$698.03 /

+4.68 (+0.67%)

BCE BCE
$41.50 /

+0.125 (+0.30%)

EQIX Equinix
$698.03 /

+4.68 (+0.67%)

05/13/20 RBC Capital
Equinix price target raised to $706 from $688 at RBC Capital
05/07/20 Wells Fargo
Equinix price target raised to $745 from $675 at Wells Fargo
05/07/20 JPMorgan
Equinix price target raised to $725 from $675 at JPMorgan
04/27/20 JPMorgan
JPMorgan positive on data center demand, Equinix top large cap pick
BCE BCE
$41.50 /

+0.125 (+0.30%)

05/08/20 CIBC
BCE price target lowered to C$61 from C$63 at CIBC
05/08/20 Canaccord
BCE price target raised to C$59 from C$58 at Canaccord
04/30/20 Scotiabank
BCE price target lowered to C$63 from C$64.50 at Scotiabank
04/07/20 Veritas
BCE downgraded to Sell from Buy at Veritas
EQIX Equinix
$698.03 /

+4.68 (+0.67%)

BCE BCE
$41.50 /

+0.125 (+0.30%)

EQIX Equinix
$698.03 /

+4.68 (+0.67%)

EQIX Equinix
$698.03 /

+4.68 (+0.67%)

Hot Stocks
FDA grants EUA for COVID-19 test that Aytu BioScience distributes » 08:32
06/01/20
06/01
08:32
06/01/20
08:32
AYTU

Aytu BioScience

$1.48 /

+0.09 (+6.47%)

Aytu BioScience announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

05/29/20 H.C. Wainwright
Aytu BioScience initiated with a Buy at H.C. Wainwright
09/18/19 Ladenburg
Aytu BioScience price target raised to $4.75 from $4.00 at Ladenburg
AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

Recommendations
MasterCard price target raised to $330 from $300 at Wedbush » 08:30
06/01/20
06/01
08:30
06/01/20
08:30
MA

MasterCard

$301.60 /

-0.81 (-0.27%)

Wedbush analyst Moshe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$301.60 /

-0.81 (-0.27%)

MA MasterCard
$301.60 /

-0.81 (-0.27%)

05/06/20 Stephens
Visa franchises will exit recession stronger, says Stephens
05/06/20 Stephens
MasterCard price target raised to $304 from $286 at Stephens
05/04/20 BMO Capital
Visa price target lowered to $213 from $234 at BMO Capital
04/30/20 RBC Capital
MasterCard price target raised to $308 from $287 at RBC Capital
MA MasterCard
$301.60 /

-0.81 (-0.27%)

MA MasterCard
$301.60 /

-0.81 (-0.27%)

MA MasterCard
$301.60 /

-0.81 (-0.27%)

MA MasterCard
$301.60 /

-0.81 (-0.27%)

Hot Stocks
Aytu BioScience announces Emergency Use Authorization of COVID-19 rapid test » 08:30
06/01/20
06/01
08:30
06/01/20
08:30
AYTU

Aytu BioScience

$1.48 /

+0.09 (+6.47%)

Aytu BioScience announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

05/29/20 H.C. Wainwright
Aytu BioScience initiated with a Buy at H.C. Wainwright
09/18/19 Ladenburg
Aytu BioScience price target raised to $4.75 from $4.00 at Ladenburg
AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

AYTU Aytu BioScience
$1.48 /

+0.09 (+6.47%)

Recommendations
Elastic price target raised to $95 from $85 at RBC Capital » 08:30
06/01/20
06/01
08:30
06/01/20
08:30
ESTC

Elastic

$85.97 /

+4.12 (+5.03%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$85.97 /

+4.12 (+5.03%)

ESTC Elastic
$85.97 /

+4.12 (+5.03%)

04/16/20
DA Davidson starts Elastic with a Buy on significant growth potential
04/15/20 DA Davidson
Elastic initiated with a Buy at DA Davidson
03/24/20 Oppenheimer
Elastic price target lowered to $90 from $110 at Oppenheimer
03/23/20 Jefferies
Elastic price target lowered to $60 from $75 at Jefferies
ESTC Elastic
$85.97 /

+4.12 (+5.03%)

ESTC Elastic
$85.97 /

+4.12 (+5.03%)

ESTC Elastic
$85.97 /

+4.12 (+5.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.